See our regular market updates summarising our view of the world -November : Healthcare - a full recovery imminent?

Hedge fund managers have generally been the subject of some pretty bad press over the past few years but not many have attracted such vitriol as the former hedgie turned Turing Pharmaceuticals CEO, Martin Shkreli. His decision to hike the price of a 62 year-old drug, Daraprim (used to treat parasitic infections), from $13.50 to $750 per pill overnight made him a household name for the wrong reasons. There was an immediate public backlash which culminated in, amongst other things, Hilary Clinton pledging price controls on drug companies if she were to win the mandate for the Whitehouse.  The healthcare sector plummeted in reaction to the news... click here to read more